<DOC>
	<DOC>NCT01348542</DOC>
	<brief_summary>The purpose of this study is to evaluate the effect of a 3 month medication trial of Trazodone versus 3 months of Cognitive Behavioral Therapy (CBT) in patients with chronic insomnia.</brief_summary>
	<brief_title>Study of Trazodone &amp; Cognitive Behavioral Therapy to Treat Insomnia</brief_title>
	<detailed_description>Participants with chronic insomnia associated with objective short sleep duration will be recruited to participate in a 3 month clinical trial on the efficacy of trazodone versus CBT. The primary outcome measure will be objective sleep duration as measured by both actigraphy and polysomnography. The secondary outcome measure will be subjective severity of sleep disturbance and subjective sleep duration.</detailed_description>
	<mesh_term>Sleep Initiation and Maintenance Disorders</mesh_term>
	<mesh_term>Trazodone</mesh_term>
	<criteria>Chronic insomnia with duration of more than 1 year Objective short sleep duration (&lt; 6 hours) BMI &lt; 39 Ages 3060 Men &amp; Women Major Mental Illness Substance Abuse/Dependence Sleep Apnea Periodic Limb Movement Disorder Shift Work or circadian disorders Diabetes Chronic Renal Failure, Hepatic Insufficiency, Chronic Heart Failure Current Use of hypnotics or sleep inducing sedative antidepressants</criteria>
	<gender>All</gender>
	<minimum_age>30 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>February 2017</verification_date>
	<keyword>Chronic Insomnia</keyword>
	<keyword>Short Sleep Duration</keyword>
	<keyword>Trazodone</keyword>
	<keyword>Cognitive Behavioral Therapy</keyword>
	<keyword>Efficacy</keyword>
</DOC>